3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
2
Pancreatic Ductal Adenocarcinoma
1
Biliary Tract Neoplasms
1
Interventions
Gemcitabine
4
130-nm albumin-bound paclitaxel
3
Pancreaticoduodenectomy
2
Oxaliplatin
2
Irinotecan
2
titanium silicide
1
tislelizumab
1
sonidegib
1
paricalcitol
1
mitazalimab
1
lenvatinib
1
ivosidenib
1
irinotecan sucrosofate
1
glucoraphanin
1
devimistat
1
Transurethral Resection of Prostate
1
Tissue Banks
1
Taxes
1
Specimen Handling
1
Saline Solution
1
S 1 (combination)
1
Ropivacaine
1
Robotic Surgical Procedures
1
Radiomics
1
Positron Emission Tomography Computed Tomography
1
Parturition
1
PEGPH20
1
Neoadjuvant Therapy
1
Magnetic Resonance Spectroscopy
1
Losartan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pancreatic Ductal Adenocarcinoma
×
mitazalimab
×
Gastrointestinal
×
Clear all
NCT07199764
2026-03-06
IGNITE
University of Pennsylvania
Phase 2
Recruiting
100 enrolled